New developments in tetracycline antibiotics: Glycylcyclines and tetracycline efflux pump inhibitors

Chopra, Ian

doi:10.1016/s1368-7646(02)00051-1

Cited by 143Antibiotic Resistance in BacteriaAntimicrobial Resistance in StaphylococcusAntibiotics Pharmacokinetics and Efficacy

New developments in tetracycline antibiotics: Glycylcyclines and tetracycline efflux pump inhibitors

Chopra, Ian·2002·Drug Resistance Updates

DOI 10.1016/s1368-7646(02)00051-1

Open this paper in CoChat — free account

Abstract

The tetracyclines, discovered in the 1940s, are a well-established class of antibiotics that still have a role in treating microbial infections in man. However, the widespread emergence of bacterial resistance due to efflux and ribosomal protection mechanisms has severely limited their effectiveness. A new generation of tetracyclines, the glycylcyclines, has been developed to overcome resistance to earlier tetracyclines. One of the new glycylcyclines, 9-t-butylglyclamido-minocycline (GAR-936, tigecycline) is currently undergoing clinical trials. This review considers the current status of glycylcyclines and the possibility that resistance to these agents might arise in the future. Other approaches are also being taken to address the emergence of resistance to tetracyclines. Recently, a number of tetracycline efflux pump inhibitors have been discovered that might be used in combination with earlier tetracyclines to restore their activity against resistant organisms. However, the development of tetracycline efflux pump inhibitors is complicated by the occurrence of several efflux pump sub-families and by the presence of both efflux and ribosomal protection mechanisms in the same organism, especially in naturally occurring, Gram-positive clinical isolates.

Integrity signals

Registry

Crossref · 10.1016/s1368-7646(02)00051-1

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Third-generation tetracycline derivatives such as tigecycline display enhanced antimicrobial activity, overcoming efflux and ribosome protection mechanisms.
“The third generation of tetracycline derivatives, such as tigecycline (Tgc), display enhanced antimicrobial activity, overcoming efflux and ribosome protection mechanisms (6)(7)(8).”
From Structural basis for TetM-mediated tetracycline resistance (2012) · cites this paper as [6]

Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517 · see citing works
High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Oliver, A., Cantón, R., Campo, P., Baquero, F., & Blázquez, J. (2000) · Science · doi:10.1126/science.288.5469.1251 · Cited by 1,466 · see citing works
The Challenge of Antibiotic Resistance
Levy, S. B. (1998) · Scientific American · doi:10.1038/scientificamerican0398-46 · Cited by 867 · see citing works
High Mutation Frequencies Among Escherichia coli and Salmonella Pathogens
LeClerc, J. E., Li, B., Payne, W. L., & Cebula, T. A. (1996) · Science · doi:10.1126/science.274.5290.1208 · Cited by 818 · see citing works
In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9- t -Butylglycylamido Derivative of Minocycline (GAR-936)
Petersen, P. J., Jacobus, N. V., Weiss, W. J., Sum, P., & TESTA, R. T. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.738 · Cited by 413 · see citing works
Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori
Björkholm, B., Sjölund, M., Falk, P. G., Berg, O. G., Engstrand, L. G., & Andersson, D. I. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241517298 · Cited by 404 · see citing works
Multiple antibiotic resistance and efflux
Nikaido, H. (1998) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(98)80083-0 · Cited by 301 · see citing works
The Pharmaceutical Industry
Cimoli, M. (2013) · Routledge eBooks · doi:10.4324/9780203056219-22 · Cited by 198 · see citing works
Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates
Gales, A. C., & Jones, R. N. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00092-9 · Cited by 189 · see citing works
Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936
Sum, P., & Petersen, P. J. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00216-4 · Cited by 173 · see citing works
Mutator clones of Neisseria meningitidis in epidemic serogroup A disease
Richardson, A. R., Yu, Z., Popović, T., & Stojiljković, I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092568699 · Cited by 164 · see citing works
Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria.
Lomovskaya, O., & Watkins, W. (2001) · PubMed · Cited by 159 · see citing works
Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet(M)- and Tet(O)-mediated ribosomal protection
Bergeron, J., Ammirati, M., Danley, D., James, L., Norcia, M., Retsema, J., Strick, C. A., Su, W. G., Sutcliffe, J., & Wondrack, L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2226 · Cited by 157 · see citing works
In Vitro Activities of Tigecycline (GAR-936) against Recently Isolated Clinical Bacteria in Spain
Betriú, C., Rodríguez-Avial, I., Sánchez, B. A., Gómez, M., Alvarez, J. A. O., & Picazo, J. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.892-895.2002 · Cited by 127 · see citing works
In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines
TESTA, R. T., Petersen, P. J., Jacobus, N. V., Sum, P., LEE, V. J., & Tally, F. P. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.11.2270 · Cited by 121 · see citing works
Glycylcyclines: third-generation tetracycline antibiotics
Chopra, I. (2001) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00081-9 · Cited by 121 · see citing works
Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines
Sum, P., LEE, V. J., TESTA, R. T., Hlavka, J. J., Ellestad, G. A., Bloom, J. D., Gluzman, Y., & Tally, F. P. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00027a023 · Cited by 118 · see citing works
In Vitro Activities of the Glycylcycline GAR-936 against Gram-Positive Bacteria
Boucher, H. W., Wennersten, C. B., & Eliopoulos, G. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2225-2229.2000 · Cited by 98 · see citing works
Reversal of Tetracycline Resistance Mediated by Different Bacterial Tetracycline Resistance Determinants by an Inhibitor of the Tet(B) Antiport Protein
Nelson, M. L., & Levy, S. B. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1719 · Cited by 96 · see citing works
Mutations in the Interdomain Loop Region of the tetA (A) Tetracycline Resistance Gene Increase Efflux of Minocycline and Glycylcyclines
Tuckman, M., Petersen, P. J., & Projan, S. J. (2000) · Microbial Drug Resistance · doi:10.1089/mdr.2000.6.277 · Cited by 84 · see citing works
Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes
Miller, K. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf044 · Cited by 79 · see citing works
Inhibition of protein synthesis occurring on tetracycline-resistant, TetM-protected ribosomes by a novel class of tetracyclines, the glycylcyclines
Rasmussen, B. A., Gluzman, Y., & Tally, F. P. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.7.1658 · Cited by 62 · see citing works
Insertional inactivation of mutS in Staphylococcus aureus reveals potential for elevated mutation frequencies, although the prevalence of mutators in clinical isolates is low
O’Neill, A. J. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf118 · Cited by 62 · see citing works
A novel glycylcycline, 9-(N,N-dimethylglycylamido)-6-demethyl-6-deoxytetracycline, is neither transported nor recognized by the transposon Tn10-encoded metal-tetracycline/H+ antiporter
Someya, Y., Yamaguchi, A., & Sawai, T. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.247 · Cited by 58 · see citing works
Research and development of antibacterial agents
Chopra, I. (1998) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(98)80080-5 · Cited by 48 · see citing works
In vitro activities of two glycylcyclines against gram-positive bacteria
Eliopoulos, G. M., Wennersten, C. B., Cole, G., & Moellering, R. C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.534 · Cited by 48 · see citing works
Mutations in the tetA(B) gene that cause a change in substrate specificity of the tetracycline efflux pump
Guay, G. G., Tuckman, M., & Rothstein, D. M. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.857 · Cited by 44 · see citing works
Origin of tetracycline efflux proteins: conclusions from nucleotide sequence analysis
Sheridan, R. P., & Chopra, I. (1991) · Molecular Microbiology · doi:10.1111/j.1365-2958.1991.tb00763.x · Cited by 36 · see citing works
"Glycylcyclines". 3. 9-Aminodoxycyclinecarboxamides
Barden, T. C., Buckwalter, B. L., TESTA, R. T., Petersen, P. J., & LEE, V. J. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00046a003 · Cited by 34 · see citing works
Comparative in-vitro activities of RP59500 (quinupristin/dalfopristin), CL 329,998, CL 331,002, trovafloxacin, clinafloxacin, teicoplanin and vancomycin against Gram-positive bacteria
Shonekan, D., Handwerger, S., & Mildvan, D. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/39.3.405 · Cited by 34 · see citing works
Detection of tetracyclines and efflux pump inhibitors
Rothstein, D. M., McGlynn, M., Bernan, V. S., McGahren, J., Zaccardi, J., Cekleniak, N., & Bertrand, K. P. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.8.1624 · Cited by 31 · see citing works
In vitro activities of two glycylcyclines
Wise, R. A., & Andrews, J. M. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.5.1096 · Cited by 30 · see citing works
N,N-dimethylglycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocci
Goldstein, F. W., Kitzis, M.-D., & Acar, J. F. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.2218 · Cited by 30 · see citing works
Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines
Kenny, G. E., & Cartwright, F. D. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.11.2628 · Cited by 24 · see citing works
Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclines
Weiss, J., Jacobus, N. V., Petersen, P. J., & TESTA, R. T. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/36.1.225 · Cited by 21 · see citing works
Activities of the glycylcyclines N,N-dimethylglycylamido-minocycline and N,N-dimethylglycylamido-6-demethyl-6-deoxytetracycline against Nocardia spp. and tetracycline-resistant isolates of rapidly growing mycobacteria
Brown, B. A., Wallace, R. J., & Onyi, G. O. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.874 · Cited by 20 · see citing works
In-vitro activity of two glycylcyclines against enterococci resistant to other agents
Fraise, A. P., Brenwald, N. P., Andrews, J. M., & Wise, R. A. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/35.6.877 · Cited by 19 · see citing works
Susceptibilities of Neisseria gonorrhoeae to the glycylcyclines
Whittington, W. L. H., Roberts, M. C., Hale, J., & Holmes, K. K. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.8.1864 · Cited by 17 · see citing works
In vitro activity of DMG-mino and DMG-DM Dot, two new glycylcyclines, against anaerobic bacteria
Nord, C. E., Lindmark, A., & Persson, I. (1993) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02098471 · Cited by 13 · see citing works
In vitro activities of two new glycylcyclines, N,N-dimethylglycylamido derivatives of minocycline and 6-demethyl-6-deoxytetracycline, against 339 strains of anaerobic bacteria
Wexler, H. M., Molitoris, E., & Finegold, S. M. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.10.2513 · Cited by 13 · see citing works
Activity of glycylcyclines CL 329998 and CL 331002 against minocycline-resistant and other strains of methicillin-resistant Staphylococcus aureus
Hamilton-Miller, J. M. T., & Shah, S. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/37.6.1171 · Cited by 11 · see citing works
ChemInform Abstract: Glycylcyclines. Part 1. A New Generation of Potent Antibacterial Agents Through Modification of 9‐Aminotetracyclines.
Sum, P., LEE, V. J., TESTA, R. T., Hlavka, J. J., Ellestad, G. A., Bloom, J. D., Gluzman, Y., & Tally, F. P. (1994) · ChemInform · doi:10.1002/chin.199417260 · Cited by 2 · see citing works

Flagged first, then by citations

Sorted by citations

Coagulase-Negative Staphylococci
Becker, K., Heilmann, C., & Peters, G. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00109-13 · Cited by 1,677 · see citing works
Efflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082 · see citing works
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,073 · see citing works
Update on acquired tetracycline resistance genes
Roberts, M. C. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.02.034 · Cited by 1,010 · see citing works
Efflux-Mediated Drug Resistance in Bacteria
Li, X.-Z., & Nikaido, H. (2004) · Drugs · doi:10.2165/00003495-200464020-00004 · Cited by 803 · see citing works
Bacterial Multidrug Efflux Pumps: Much More Than Antibiotic Resistance Determinants
Blanco, P., Hernando‐Amado, S., Reales‐Calderón, J. A., Corona, F., Lira, F., Alcalde‐Rico, M., Bernardini, A., Sánchez, M. B., & Martínez, J. L. (2016) · Microorganisms · doi:10.3390/microorganisms4010014 · Cited by 667 · see citing works
Natural products to drugs: natural product derived compounds in clinical trials
Butler, M. S. (2005) · Natural Product Reports · doi:10.1039/b402985m · Cited by 493 · see citing works
The A-Z of bacterial translation inhibitors
Wilson, D. N. (2009) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409230903307311 · Cited by 322 · see citing works
Pharmacokinetics of Tigecycline after Single and Multiple Doses in Healthy Subjects
Muralidharan, G., Micalizzi, M., Speth, J., Raible, D. G., & Troy, S. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.220-229.2005 · Cited by 333 · see citing works
Bacterial efflux systems and efflux pumps inhibitors
Marquez, B. (2005) · Biochimie · doi:10.1016/j.biochi.2005.04.012 · Cited by 269 · see citing works
Strategies to Overcome Antimicrobial Resistance (AMR) Making Use of Non-Essential Target Inhibitors: A Review
Annunziato, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235844 · Cited by 259 · see citing works
Potential of old-generation antibiotics to address current need for new antibiotics
Falagas, M. E., Grammatikos, A. P., & Michalopoulos, A. S. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.593 · Cited by 247 · see citing works
Inhibitors of efflux pumps in Gram-negative bacteria
Pagès, J., Masi, M., & Barbe, J. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.06.006 · Cited by 239 · see citing works
Structural basis for TetM-mediated tetracycline resistance
Dönhöfer, A., Franckenberg, S., Wickles, S., Berninghausen, O., Beckmann, R., & Wilson, D. N. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208037109 · Cited by 217 · see citing works
Functional, biophysical, and structural bases for antibacterial activity of tigecycline
Olson, M. W., Ruzin, A., Feyfant, E., Rush, T. S., O'Connell, J., & Bradford, P. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01499-05 · Cited by 207 · see citing works
The historical delivery of antibiotics from microbial natural products—Can history repeat?
Peláez, F. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.010 · Cited by 201 · see citing works
Interaction of antibacterial compounds with RND eﬄux pumps in Pseudomonas aeruginosa
Dreier, J., & Ruggerone, P. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00660 · Cited by 190 · see citing works
Modulation of Bacterial Multidrug Resistance Efflux Pumps of the Major Facilitator Superfamily
Kumar, S. H., Mukherjee, M. M., & Varela, M. F. (2013) · International Journal of Bacteriology · doi:10.1155/2013/204141 · Cited by 167 · see citing works
Tigecycline: A glycylcycline antimicrobial agent
Doan, T.-L., Fung, H. B., Mehta, D., & Riska, P. F. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.08.011 · Cited by 152 · see citing works
Bacterial Efflux Pumps Involved in Multidrug Resistance and their Inhibitors: Rejuvinating the Antimicrobial Chemotherapy
Bhardwaj, A. K., & Mohanty, P. (2012) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/157489112799829710 · Cited by 148 · see citing works
Impact of metal coordination on the antibiotic and non-antibiotic activities of tetracycline-based drugs
Guerra, W., Silva, P. P., Terenzi, H. F., & Pereira-Maia, E. C. (2016) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2016.04.009 · Cited by 138 · see citing works
Inducement and Reversal of Tetracycline Resistance in Escherichia coli K-12 and Expression of Proton Gradient-Dependent Multidrug Efflux Pump Genes
Viveiros, M., de Jesus, A. P., Brito, M., Leandro, C., Martins, M., Ordway, D. J., Molnar, A. M., Molnar, J. A., & Amaral, L. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3578-3582.2005 · Cited by 135 · see citing works
Effects of Efflux Transporter Genes on Susceptibility of Escherichia coli to Tigecycline (GAR-936)
Hirata, T., Saito, A., Nishino, K., Tamura, N., & Yamaguchi, A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2179-2184.2004 · Cited by 122 · see citing works
RamA, a Transcriptional Regulator, and AcrAB, an RND-Type Efflux Pump, are Associated with Decreased Susceptibility to Tigecycline in Enterobacter cloacae
Keeney, D. R., Ruzin, A. V., & Bradford, P. A. (2007) · Microbial Drug Resistance · doi:10.1089/mdr.2006.9990 · Cited by 111 · see citing works
Antimicrobial Resistance in Methicillin-Resistant Staphylococcus aureus to Newer Antimicrobial Agents
Watkins, R., Holubar, M. K., & David, M. Z. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01216-19 · Cited by 108 · see citing works
Efflux systems in bacterial pathogens: An opportunity for therapeutic intervention? An industry view
Lynch, A. S. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.021 · Cited by 102 · see citing works
Do physiological roles foster persistence of drug/multidrug-efflux transporters? A case study
KRULWICH, T. A., Lewinson, O., Padan, E., & Bibi, E. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1181 · Cited by 97 · see citing works
AcrAB Efflux Pump Plays a Role in Decreased Susceptibility to Tigecycline in Morganella morganii
Ruzin, A. V., Keeney, D. R., & Bradford, P. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.791-793.2005 · Cited by 93 · see citing works
The threat from the pink corner
Livermore, D. M. (2003) · Annals of Medicine · doi:10.1080/07853890310001609 · Cited by 92 · see citing works
Performance of Traditional and Emerging Water-Treatment Technologies in the Removal of Tetracycline Antibiotics
Wang, F., Wang, Z., Zhao, Y., & Zhang, J. (2024) · Catalysts · doi:10.3390/catal14040269 · Cited by 90 · see citing works
Update on Acinetobacter Species: Mechanisms of Antimicrobial Resistance and Contemporary In Vitro Activity of Minocycline and Other Treatment Options
Castanheira, M., Mendes, R. E., & Jones, R. N. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu706 · Cited by 85 · see citing works
Understanding efflux in Gram-negative bacteria: opportunities for drug discovery
Schweizer, H. P. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.688949 · Cited by 84 · see citing works
Occurrence of Tetracycline Resistance Genes among Escherichia coli Isolates from the Phase 3 Clinical Trials for Tigecycline
Tuckman, M., Petersen, P. J., Howe, A. Y. M., Orlowski, M., Mullen, S., Chan, K., Bradford, P. A., & Jones, C. H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00625-07 · Cited by 83 · see citing works
Tetraciclinas, sulfamidas y metronidazol
Vicente, D. A., & Pérez‐Trallero, E. (2010) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2009.10.002 · Cited by 80 · see citing works
Cryo-EM structure of the tetracycline resistance protein TetM in complex with a translating ribosome at 3.9-Å resolution
Arenz, S., Nguyen, F., Beckmann, R., & Wilson, D. N. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501775112 · Cited by 68 · see citing works
In vitro and in silico inhibitory effects of synthetic and natural eugenol derivatives against the NorA efflux pump in Staphylococcus aureus
Muniz, D. F., Barbosa, C. R. D. S., de Menezes, I. R. A., de Sousa, E. O., Pereira, R. L. S., Júnior, J. T. C., Pereira, P. S., de Matos, Y. M. L. S., da Costa, R. H. S., Oliveira–Tintino, C. D. D. M., et al. (2020) · Food Chemistry · doi:10.1016/j.foodchem.2020.127776 · Cited by 67 · see citing works
Effects of Age and Sex on Single-Dose Pharmacokinetics of Tigecycline in Healthy Subjects
Muralidharan, G., Fruncillo, R. J., Micalizzi, M., Raible, D. G., & Troy, S. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1656-1659.2005 · Cited by 64 · see citing works
Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018
Pfaller, M. A., Huband, M. D., Shortridge, D., & Flamm, R. K. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02488-19 · Cited by 64 · see citing works
Dissemination and prevalence of plasmid-mediated high-level tigecycline resistance gene tet (X4)
Zhang, S., Wen, J., Wang, Y., Wang, M., Jia, R., Chen, S., Liu, M., Zhu, D., Zhao, X., Wu, Y., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.969769 · Cited by 59 · see citing works
Tigecycline: An investigational glycylcycline antimicrobialwith activity against resistant gram-positive organisms
Garrison, M. W., Neumiller, J. J., & Setter, S. M. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.01.007 · Cited by 60 · see citing works
The inhibition the Tet(K) efflux pump of tetracycline resistant Staphylococcus epidermidis by essential oils from three Salvia species
Chovanová, R., Mezovská, J., Vaverková, Š., & Mikulášová, M. (2015) · Letters in Applied Microbiology · doi:10.1111/lam.12424 · Cited by 59 · see citing works
Pharmacokinetics and Safety Profile of Tigecycline in Children Aged 8 to 11 Years With Selected Serious Infections: A Multicenter, Open-Label, Ascending-Dose Study
Purdy, J., Jouve, S., Yan, J. L., Balter, I. H., Dartois, N., Cooper, C. A., & Korth-Bradley, J. M. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.12.010 · Cited by 58 · see citing works
A Novel Indole Compound That Inhibits Pseudomonas aeruginosa Growth by Targeting MreB Is a Substrate for MexAB-OprM
Robertson, G. T., Doyle, T. B., Du, Q., Duncan, L. R., Mdluli, K. E., & Lynch, A. S. (2007) · Journal of Bacteriology · doi:10.1128/jb.00805-07 · Cited by 54 · see citing works
The tetA gene decreases tigecycline sensitivity of Salmonella enterica isolates
Akiyama, T., Presedo, J., & Khan, A. A. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.04.017 · Cited by 51 · see citing works
Putative dioxygen-binding sites and recognition of tigecycline and minocycline in the tetracycline-degrading monooxygenase TetX
Volkers, G., Damas, J. M., Palm, G. J., Panjikar, S., Soares, C. M., & Hinrichs, W. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444913013802 · Cited by 45 · see citing works
Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial
Chen, Z., Wu, J., Zhang, Y., Wei, J., Leng, X.-S., Bi, J., Li, R., Yan, L., Quan, Z., Chen, X., et al. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-217 · Cited by 45 · see citing works
Protonation Patterns in Tetracycline:Tet Repressor Recognition: Simulations and Experiments
Aleksandrov, A. V., Proft, J., Hinrichs, W., & Simonson, T. (2007) · ChemBioChem · doi:10.1002/cbic.200600535 · Cited by 45 · see citing works
Natural-Product-Based Solutions for Tropical Infectious Diseases
Adegboye, O., Field, M. A., Kupz, A., Pai, S., Sharma, D., Smout, M. J., Wangchuk, P., Wong, Y., & Loiseau, C. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00348-20 · Cited by 43 · see citing works
NiFe2O4/biochar decorated porous polymer membranes for the flow-through photo-Fenton degradation of tetracycline
Leichtweis, J., Carissimi, É., Hagemann, U., Ulbricht, M., & Fischer, L. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.147203 · Cited by 42 · see citing works
Study of a hybrid process combining PACs and membrane operations for antibiotic wastewater treatment
Zhang, J., Giorno, L., & Drioli, E. (2006) · Desalination · doi:10.1016/j.desal.2005.11.004 · Cited by 41 · see citing works
Enterococcus faecalis Resistant to Linezolid: Case Series and Review of the Literature
Burleson, B. S., Ritchie, D. J., Micek, S. T., & Dunne, W. M. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.13.1225.38086 · Cited by 41 · see citing works
Doxycycline impairs neutrophil migration to the airspaces of the lung in mice exposed to intratracheal lipopolysaccharide
Moon, A., Gil, S., Gill, S. E., Chen, P., & Matute‐Bello, G. (2012) · Journal of Inflammation · doi:10.1186/1476-9255-9-31 · Cited by 36 · see citing works
Tetracyclines, Glycylcyclines, and Chloramphenicol
Moffa, M. A., & Brook, I. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00026-6 · Cited by 39 · see citing works
Pharmacokinetics and Safety of a Single Intravenous Dose of the Antibiotic Tigecycline in Patients With Cirrhosis
Korth-Bradley, J. M., Baird, S., Patat, A. A., Troy, S. M., Böhmer, G. M., Gleiter, C. H., Bücheler, R., & Morgan, M. Y. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010363477 · Cited by 35 · see citing works
Tigecycline: A Review of Properties, Applications, and Analytical Methods
da Silva, L. M., & Salgado, H. R. N. (2010) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3181dda54f · Cited by 33 · see citing works
Comparison of Antimicrobial Resistance in Escherichia coli Strains Isolated From Healthy Poultry and Swine Farm Workers Using Antibiotics in Korea
Cho, S.-H., Lim, Y.-S., & Kang, Y.-H. (2012) · Osong Public Health and Research Perspectives · doi:10.1016/j.phrp.2012.07.002 · Cited by 32 · see citing works
Evaluation of antimicrobial activity of the hydrolate of Coridothymus capitatus (L.) Reichenb. fil. (Lamiaceae) alone and in combination with antimicrobial agents
Marino, A., Nostro, A., Mandras, N., Roana, J., Ginestra, G., Miceli, N., Taviano, M. F., Gelmini, F., Beretta, G., & Tullio, V. C. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-2877-x · Cited by 32 · see citing works
Tetraciclinas, sulfamidas y metronidazol
Pérez‐Trallero, E., & Iglesias, L. (2003) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(03)72999-1 · Cited by 32 · see citing works
Tetracyclines and Chloramphenicol
Salvatore, M., & Meyers, B. R. (2010) · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases · doi:10.1016/b978-0-443-06839-3.00027-8 · Cited by 31 · see citing works
In Vitro Activity of KBP-7072, a Novel Third-Generation Tetracycline, against 531 Recent Geographically Diverse and Molecularly Characterized Acinetobacter baumannii Species Complex Isolates
Huband, M. D., Mendes, R. E., Pfaller, M. A., Lindley, J. M., Strand, G. J., Benn, V. J., Zhang, J., Li, L., Zhang, M., Tan, X., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02375-19 · Cited by 30 · see citing works
NorA, Tet(K), MepA, and MsrA Efflux Pumps in Staphylococcus aureus, their Inhibitors and 1,8-Naphthyridine Sulfonamides
Coutinho, H. D. M., Oliveira–Tintino, C. D. D. M., Muniz, D. F., Barbosa, C. R. D. S., Pereira, R. L. S., Begnini, I. M., Rebelo, R. A., da Silva, L. E., Mireski, S. L., Nasato, M. C., et al. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612829666221212101501 · Cited by 27 · see citing works
Tetracycline-Tet Repressor Binding Specificity: Insights from Experiments and Simulations
Aleksandrov, A. V., Schuldt, L., Hinrichs, W., & Simonson, T. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.08.050 · Cited by 26 · see citing works
Binding of Tetracyclines to Elongation Factor Tu, the Tet Repressor, and the Ribosome: A Molecular Dynamics Simulation Study
Aleksandrov, A. V., & Simonson, T. (2008) · Biochemistry · doi:10.1021/bi801726q · Cited by 24 · see citing works
Cloacal Lactobacillus Isolates from Broilers Often Display Resistance Toward Tetracycline Antibiotics
Cauwerts, K., Pasmans, F., Devriese, L. A., Haesebrouck, F., & Decostere, A. (2006) · Microbial Drug Resistance · doi:10.1089/mdr.2006.12.284 · Cited by 24 · see citing works
Reassessment of tigecycline bone concentrations in volunteers undergoing elective orthopedic procedures
Bhattacharya, I., Gotfried, M. H., Ji, A., Saunders, J. P., Gourley, I. S., Diehl, A. M., & Korth-Bradley, J. M. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.201 · Cited by 22 · see citing works
Evaluation of a Potential Tigecycline‐Warfarin Drug Interaction
Zimmerman, J. J., Raible, D. G., Harper, D. M., Matschke, K. T., & Speth, J. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.7.895 · Cited by 22 · see citing works
Synthesis and Antibacterial Activity of Doxycycline Neoglycosides
Zhang, J., Ponomareva, L. V., Marchillo, K., Zhou, M., Andes, D. R., & Thorson, J. S. (2013) · Journal of Natural Products · doi:10.1021/np4003096 · Cited by 20 · see citing works
Characterization of virulence and antimicrobial resistance genes of Aeromonas media strain SD/21–15 from marine sediments in comparison with other Aeromonas spp.
Dubey, S., Ager-Wick, E., Peng, B., Evensen, Ø., Sørum, H. R., & Munang’andu, H. M. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1022639 · Cited by 19 · see citing works
Effects of Menthol Supplementation in Feedlot Cattle Diets on the Fecal Prevalence of Antimicrobial-Resistant Escherichia coli
Aperce, C. C., Amachawadi, R. G. G., Bibber-Krueger, C. L. V., Nagaraja, T. G., Scott, H. M., Vinasco-Torre, J., & Drouillard, J. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168983 · Cited by 19 · see citing works
The Co-occurrence of NDM-5, MCR-1, and FosA3-Encoding Plasmids Contributed to the Generation of Extensively Drug-Resistant Klebsiella pneumoniae
Zhou, Y., Ai, W., Cao, Y., Guo, Y., Wu, X., Wang, B., Rao, L., Xu, Y., Zhao, H., Wang, X., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.811263 · Cited by 18 · see citing works
Synthesis and structure elucidation of ZnFe2O4/IRMOF-3/GO for the drug delivery of tetracycline and evaluation of their antibacterial activities
Sanaei-Rad, S., Ghasemzadeh, M. A., & Aghaei, S. S. (2021) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2021.122221 · Cited by 17 · see citing works
Absence of an Interaction Between Tigecycline and Digoxin in Healthy Men
Zimmerman, J. J., Harper, D. M., Matschke, K. T., Speth, J., Raible, D. G., & Fruncillo, R. J. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.6.835 · Cited by 17 · see citing works
Comparison of Tigecycline and Vancomycin for Treatment of Experimental Foreign-Body Infection Due to Methicillin-Resistant Staphylococcus aureus
Vaudaux, P. E., Fleury, B., Gjinovci, A., Huggler, E., Bento, M., & Lew, D. P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01612-08 · Cited by 16 · see citing works
Minocycline and tigecycline form higher-order Ca2+ complexes of stronger affinity than tetracycline
Arias, K., Robinson, S. G., Lyngaas, S. S., Cherala, S. S., Hartzell, M., Mei, S., Vilic, A., Girel, J. K., Kuemmell, A., Vrettos, J. S., et al. (2015) · Inorganica Chimica Acta · doi:10.1016/j.ica.2015.10.037 · Cited by 15 · see citing works
Efflux Pump Inhibitors Derived From Natural Sources as Novel Antibacterial Agents Against Pseudomonas aeruginosa: A Review
Islamieh, D. I., Afshar, D., Yousefi, M., & Esmaeili, D. (2018) · International Journal of Medical Reviews · doi:10.29252/ijmr-050303 · Cited by 15 · see citing works
Contribution of Hospital Wastewater to the Spread of Antibiotic Resistance in Comparison to Non - Health Institution
Elmanama, A. A., Kichaoui, A. Y. E., & Mohsin, M. (2006) · Cited by 15 · see citing works
A Comprehensive Review of Antibiotics and Antimicrobial Resistance in the Aquaculture Sector of the World and Bangladesh
Afroze, S., Faisal, M., Khan, M. N. A., & Barua, H. (2025) · International Journal of Microbiology · doi:10.1155/ijm/8818516 · Cited by 15 · see citing works
Prevalence of Antimicrobial Resistance in Escherichia coli Strains Isolated from Fishery Workers
Shin, H.-H., & Cho, S.-H. (2013) · Osong Public Health and Research Perspectives · doi:10.1016/j.phrp.2013.03.001 · Cited by 13 · see citing works
Activity of the Novel Aminomethylcycline KBP-7072 and Comparators against 1,057 Geographically Diverse Recent Clinical Isolates from the SENTRY Surveillance Program, 2019
Huband, M. D., Thompson, J. D., Gurung, N. D., Liu, Q., Li, L., Zhang, J., Streit, J. M., & Castanheira, M. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01397-21 · Cited by 14 · see citing works
Multidrug Efflux Pumps and Their Inhibitors Characterized by Computational Modeling
Ramaswamy, V. K., Cacciotto, P., Malloci, G., Ruggerone, P., & Vargiu, A. V. (2016) · Springer eBooks · doi:10.1007/978-3-319-39658-3_30 · Cited by 12 · see citing works
Meta-analysis and empirical research on the effectiveness of biochar in remediating tetracyclines pollution in water bodies
Li, N., Zhu, X., Miao, Y., Wang, Z., Lin, C. S. K., & Li, C. (2025) · Bioresource Technology · doi:10.1016/j.biortech.2025.132917 · Cited by 11 · see citing works
Fighting bacterial resistance: approaches, challenges, and opportunities in the search for new antibiotics.Part 1. Antibiotics used in clinical practice: mechanisms of action and the development of bacterial resistance
ZHIVICH, A. B. (2017) · Microbiology Independent Research Journal (MIR Journal) · doi:10.18527/2500-2236-2017-4-1-31-51 · Cited by 12 · see citing works
Cytotoxicity and Cellular Accumulation of Palladium(II) Complexes of Tetracyclines
Paula, F. C. S. D., Guerra, W., Silva, I. R., Silveira, J. N., Botelho, F. V., Vieira, L. Q., & Pereira-Maia, E. C. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890193 · Cited by 11 · see citing works
In Vitro Activity Analysis of a New Polymyxin, SPR741, Tested in Combination with Antimicrobial Agents against a Challenge Set of Enterobacteriaceae , Including Molecularly Characterized Strains
Mendes, R. E., Rhomberg, P. R., Lister, T., Cotroneo, N. S., Parr, T. R., & Castanheira, M. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00742-20 · Cited by 10 · see citing works
The preparation of hybrid silicon quantum dots by one-step synthesis for tetracycline detection and antibacterial applications
Chi, Y., Sun, W., Zhou, L., Pei, S., Zeng, H., Cheng, Y., & Chai, S. (2023) · Analytical Methods · doi:10.1039/d2ay02102a · Cited by 9 · see citing works
Bioavailability of tetracyclines is substantially increased by administration of cyclosporine A, a non-specific efflux-pump blocker
Ziółkowski, H. (2023) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2023.100493 · Cited by 9 · see citing works
RESISTANCE TO TETRACYCLINE IN ESCHERICHIA COLI AND STAPHYLOCOCCUS AUREUS: BRIEF OVERVIEW ON MECHANISMS OF RESISTANCE AND EPIDEMIOLOGY
Velhner, M., & Milanov, D. S. (2016) · Archives of Veterinary Medicine · doi:10.46784/e-avm.v8i1.103 · Cited by 9 · see citing works
Tigecycline in vitro Activity against Gram-Negative and Gram-Positive Pathogens Collected in Italy
Roveta, S., Marchese, A. E., & Debbia, E. A. (2007) · Chemotherapy · doi:10.1159/000112415 · Cited by 9 · see citing works
Fluorimetric determination of tetracycline antibiotics in animal derived foods using boron and nitrogen co-doped ceria-based nanoparticles
Li, Q., Fan, P., Hao, Z., Ni, S., Wu, Q., & Li, L. (2024) · Microchimica Acta · doi:10.1007/s00604-024-06214-6 · Cited by 8 · see citing works
Therapeutic Limitations due to Antibiotic Drug Resistance: Road to Alternate Therapies
(2014) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781608059126114030004 · Cited by 8 · see citing works
Proteus penneri
Cantón, R., Sánchez-Moreno, M. P., & Reilly, M. I. M. (2006) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13094272 · Cited by 8 · see citing works
Newer antibiotics for the treatment of respiratory tract infections
Blasi, F., Tarsia, P., Cosentini, R., & Valenti, V. (2004) · Current Opinion in Pulmonary Medicine · doi:10.1097/00063198-200405000-00008 · Cited by 8 · see citing works
Prevalence of antibiotic resistance genes in bacteria from Gomti and Ganga rivers: implications for water quality and public health
Naznine, F., Ansari, M. I., Aafreen, U., Singh, K., Verma, R., Dey, M., Malik, Y. S., & Khubaib, M. (2024) · Environmental Monitoring and Assessment · doi:10.1007/s10661-024-13114-y · Cited by 7 · see citing works
Optimization of tigecycline dosage regimen for different infections in the patients with hepatic or renal impairment
Li, M. X., Li, N., Zhu, L., & Liu, W. (2020) · Journal of Chemotherapy · doi:10.1080/1120009x.2020.1800318 · Cited by 7 · see citing works
A Natural Lipotrisaccharide and Its Derivatives Selectively Lyse Streptococcus pneumoniae via Interaction with Cell Membrane
Liu, B., Liu, X., Zhang, J., & Liu, G. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00008 · Cited by 6 · see citing works
Tetracycline-ferrite nanocomposites formed via high-energy ball milling and the influence of milling conditions
Branham, M. L., Moyo, T., Abdallah, H. M. I., & Masina, P. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.09.017 · Cited by 6 · see citing works
Multidrug resistance and major facilitator superfamily antimicrobial efflux pumps of the ESKAPEE pathogen Staphylococcus aureus
Aborah, E., Ayitah, M., Boafo, K. F., Ortiz-Alegria, A., Lekshmi, M., Dhanush, C. K., Kumar, S. H., & Varela, M. F. (2025) · Exploration of Drug Science · doi:10.37349/eds.2025.100897 · Cited by 5 · see citing works
Characterization and Isolation of the Major Biologically Active Metabolites Isolated from Ficus retusa and Their Synergistic Effect with Tetracycline against Certain Pathogenic-Resistant Bacteria
Alqahtani, A., Marrez, D. A., Aleraky, M., Fagir, N. A., Alqahtani, O. S., Othman, S., Raey, M. A. E., & Attia, H. G. (2022) · Pharmaceuticals · doi:10.3390/ph15121473 · Cited by 5 · see citing works
Secondary Metabolites and Toxins of Microbial Origin for the Treatment of Diseases
Baria, D., Shah, U., Egbuna, C., & Mtewa, A. G. (2020) · doi:10.1002/9781119650034.ch11 · Cited by 5 · see citing works
Tetracyclines and Tetracycline Derivatives
Nelson, M. L., & Levy, S. B. (2011) · Elsevier eBooks · doi:10.1016/b978-0-08-088504-9.00210-5 · Cited by 4 · see citing works

Glycylcyclines: third-generation tetracycline antibiotics
Chopra, I. (2001) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00081-9 · Cited by 121 · see citing works
Tigecycline: a case study
Loh, E., Ellis‐Grosse, E. J., Petersen, P. J., Sum, P., & Projan, S. J. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.3.403 · Cited by 2 · see citing works
Recent Developments in Tetracycline Antibiotics
Sum, P., Sum, F. W., & Projan, S. J. (1970) · Current Pharmaceutical Design · doi:10.2174/138161280401221007113202 · Cited by 71 · see citing works
The Glycylcyclines
Zhanel, G. G., Homenuik, K., Nichol, K. A., Noreddin, A. M., Vercaigne, L. M., Embil, J. M., Gin, A. S., Karlowsky, J. A., & Hoban, D. J. (2004) · Drugs · doi:10.2165/00003495-200464010-00005 · Cited by 305 · see citing works
Genetic Determinants of Tetracycline Resistance and their Effect on Tetracycline and Glycylcycline Antibiotics
Jones, C. H., Murphy, E., & Bradford, P. A. (2008) · Anti-Infective Agents · doi:10.2174/187152108783954650 · Cited by 5 · see citing works

Authors: Chopra, I.
Affiliations: University of Leeds (GB)
Corresponding author: Chopra, Ian
Venue: Drug Resistance Updates
Publisher: Elsevier BV
Published: 2002-06
Volume: 5
Issue: 3-4
Pages: 119-125
ISSN: 1368-7646 (ISSN-L)
DOI: 10.1016/s1368-7646(02)00051-1
OpenAlex: W1970691146
Cited by: 143
References: 42
Citations by year: 2026: 4 · 2025: 6 · 2024: 5 · 2023: 3 · 2022: 5 · 2021: 4 · 2020: 7 · 2019: 3 · 2018: 3 · 2017: 2 · 2016: 7 · 2015: 5 · 2014: 6 · 2013: 8 · 2012: 9
FWCI: 3.50
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Drug Resistance Updates (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
Health Sciences › Medicine › Pharmacology › Antibiotics Pharmacokinetics and Efficacy
Keywords: tetracycline, glycylcyclines, tigecycline, antibiotic resistance, efflux pumps, multidrug resistance, Gram-positive bacteria, combination therapy
MeSH terms: Tigecycline, Humans, Microbial Sensitivity Tests, Minocycline, Structure-Activity Relationship, Tetracycline Resistance, Tetracyclines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

New developments in tetracycline antibiotics: Glycylcyclines and tetracycline efflux pump inhibitors

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks